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Abstract 
Purpose: There is paucity in the studies that assess dental implants replacing failed dental implants due to peri-
implantitis. This study aims to evaluate the clinical outcomes of these implants in terms of implant survival and 
marginal bone loss.
Methods: Patients in this retrospective study were selected if having one or more implants removed due to peri-
implantitis and the placement and loading of dental implants in the same region from April 2010 to December 2019. 
Information was collected about the patient’s demographic data, implant dimensions, surgical and prosthetic varia-
bles. Changes in peri-implant bone level, cumulative implant survival rate and technical complications were assessed.
Results: Three hundred and eighty one dental implants in 146 patients that were placed in the same posi-
tion or one-tooth position mesially/distally to the site of explantation were included. The patients’ mean age was 
63 ± 10 years. Ninety seven patients were females and 49 were males. After a mean follow-up of 34 ± 17 months, two 
implants failed. The cumulative survival rate was 99%. The marginal bone loss was −0.1 ± 0.6. Immediate or delay 
replacement of the failed implant did not affect implant survival or marginal bone stability. All the prostheses were 
screw-retained and presented the following complications: ceramic chipping (3 events), resin tooth fracture (1 event) 
and prosthetic screw loosening (1 event).
Conclusions: Dental implants replacing failed implants due to peri-implantitis would be an option in the manage-
ment of peri-implantitis. They showed high survival rate and marginal bone stability.
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Background
Modern dental implant therapy has become a predict-
able and successful restorative option to restore missing 
teeth. Recent studies estimate a 10-year implant survival 
of 96.4% of implants, when using contemporary systems 
[1]. Peri-implantitis is the most frequent complication, 
occurring in up to 20% of patients and 30% of implants 
[2]. The actual prevalence of peri-implantitis can be dif-
ficult to assess, due to the heterogeneous diagnostic and 
case definition criteria [3]. At the 2017 World Workshop 
on Periodontology, Working Group 4 has presented case 
definition of peri-implant health (no bleeding on prob-
ing and no bone loss beyond initial bone remodeling) 
and peri-implant mucositis (bleeding on probing and no 
bone loss beyond initial bone remodeling) [4]. For epi-
demiological studies, the case definition of peri-implan-
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probing, increased probing depth compared to previous 
examinations and bone loss. The adoption of these case 
definitions will help to overcome the heterogeneity in 
diagnostic and case definition criteria between studies.
The relevance and prevalence of peri-implantitis have 
increased as the number of implants placed and the lon-
gevity of the population have risen too [1–4]. This situa-
tion has reinforced the need for research on the causes of 
implant failure, implant removal techniques and the out-
comes of reinsertion of dental implants in previous failed 
sites.
There is no evidence-based unanimously accepted 
treatment protocol for advanced peri-implantitis [5]. The 
treatment should be tailored to the severity of the lesion, 
which ranges from mechanical debridement to implant 
removal [5].
Failed implant sites sometimes present a challenge for 
clinicians, because the alveolar bone is usually further 
reduced, resulting in greater difficulties to place a second 
set of implants [6]. This can be more critical, when the 
cause of implant failure is peri-implantitis resulting in 
a great bone defect [7]. Second implantation after early 
and/or late failure has demonstrated with some lim-
ited strength of evidence a moderate survival rate, with 
a weighted rate close to 89% of implants for implants 
placed in sites with a history of one failure and 67.1% in 
sites with a history of two implant failures [8]. Neverthe-
less the existing studies present certain heterogeneity of 
methodology and results.
Most of the previous articles in literature in this topic 
were focused on the prognosis of dental implants ana-
lyzing data from early and/or late failure, independently 
of the implant retrieval cause [8]. In contrast, this work 
aimed to answer more specifically the following clini-
cal question: What is the survival and complication of 
dental implants placed in the same region, where previ-
ous implants were failed due to peri-implantitis? This 
information could help clinicians to face the choice of 
treatment for advanced peri-implantitis. In contrast to 
previous research, this study aims to analyze the out-
comes of dental implants placed in the same region of a 
failed dental implant due to peri-implantitis.
Methods
This study was reported according to the STROBE 
(Strengthening the Reporting of Observational studies in 
Epidemiology) guidelines [9]. All procedures performed 
involving human participants were in accordance with 
the ethical standards of the institutional and/or national 
research committee and with the 1964 Helsinki declara-
tion and its later amendments. The study was approved 
by the Ethical Committee of the Araba University Hos-
pital (Expte. 2020-061). The study was performed in a 
private dental centre (Vitoria, Spain) to include patients 
who were surgically treated to remove a dental implant 
between April 2010 and December 2019.
The study is an observational retrospective study in 
which patients fulfilled the following criteria:
Inclusion criteria
1. Had an age > 18 years
2. Had one or more implants removed due to peri-
implantitis.
3. Placement and loading of dental implant in the same 
region as the explanted implant.
Exclusion criteria
1. Had implant failed due to other causes different than 
peri-implantitis
2. Had the dental implants unloaded.
3. Smokers of > 10 cigarettes per day.
4. Had uncontrolled diabetes mellitus.
5. Had a follow-up time < 12 months.
Surgical procedures
The cause of implant failure was judged to be peri-
implantitis when the bone level was ≥ 3  mm below the 
most coronal intra-osseous part of the implant.
Implant removal was performed as explained elsewhere 
using an implant removal kit (Biotechnology Institute 
S.L, Vitoria, Spain) [4]. Briefly, the kit provided a ratchet 
that was engaged into the implant connection and then 
a counter-torque was exerted by a wrench. The wrench 
provided a maximum torque of 200  Ncm. If the torque 
needed to extract the implant was higher than 200 Ncm, 
trephine bur was used to cut into the first 3–4  mm of 
implant-bone contact. The implant explantation was 
then continued with the torque wrench. After implant 
removal, the socket was carefully curetted to remove any 
granulomatous tissue. A new dental implant (Biotech-
nology Institute S.L, Vitoria, Spain) was placed either 
immediately or after tissue healing. In the case of delayed 
implant placement, the socket was grafted with plasma 
rich in growth factors (PRGF). Preparation of PRGF was 
performed with KMU 15 kit (Biotechnology Institute S.L, 
Vitoria, Spain) following the manufacturer instructions. 
Briefly, blood was collected in 9  ml citrated tubes and 
centrifuged for 8 min at room temperature [10, 11]. The 
plasma column just above the Buffy coat was divided into 
fraction 1 (F1) and fraction 2 (F2). F2 contained the high-
est platelet concentration (2–3 times higher than periph-
eral blood), whereas F1 had a similar concentration to 
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peripheral blood. To induce clot formation, 10% calcium 
chloride solution was added to F1 and F2. The F2 clot was 
used to fill the socket and F1 was used to prepare a fibrin 
membrane that covered the surgical area. In the pros-
thetic phase, definitive transepithelial abutments (BTI 
Biotechnology Institute) were connected to the implant 
at the torque recommended by the manufacturer. 
Impression making and prosthesis connection were per-
formed at the gingival level (transepithelial abutments).
In this study the principal variable of efficacy was the 
implant survival (the presence of the dental implant in 
the patient’s mouth at the last time follow-up visit). As 
secondary variables of efficacy, the marginal bone loss 
and the technical complications were assessed. For the 
calculation of the marginal bone loss, digital radiographs 
were used. The linear measurements on the radiograph 
were calibrated by the known implant length. The mesial 
and distal distances between the implant platform and 
the first bone-implant contact were measured at two 
timepoints. These timepoints were the visit of implant 
loading (baseline measurement) and the last visit of the 
patient. The change in the marginal bone level was calcu-
lated as the difference between the marginal bone level at 
baseline and at the last available radiograph. The change 
in the marginal bone level was expressed as the mean of 
the change in the mesial and distal bone levels. Implant 
success was defined according to the criteria suggested by 
Buser et al. [12]. The health scale of dental implants was 
also assessed according to the criteria suggested by the 
International Congress of Oral Implantologists (ICOI) 
Pisa Consensus Conference [13]. Technical complica-
tions such as screw loosening/fracture, ceramic fracture 
and implant fracture were also assessed.
Demographic data (age and sex), date of implant 
removal, date of the new implant insertion, implant 
position, insertion torque, bone type (pristine/regener-
ated), date of implant loading and type of prosthesis were 
assessed.
Statistical analysis
Anonymized database that included the study variables 
were generated. The qualitative variables were described 
by calculating the relative/absolute frequency. The con-
tinuous variables were described by calculating the mean, 
standard deviation and the range. The normal distribu-
tion of the variables was assessed by the Shapiro–Wilk 
test. Mann–Whitney test was used to compare the mean 
marginal bone loss between the  implants that were 
placed in the same surgical session of implant removal 
and the implants  that were placed in a second surgery. 
The cumulative implant survival rate was calculated 
with the Kaplan–Meier test. The comparison of the sur-
vival rate between immediate or delayed insertion of the 
replacing implants was performed with the Mantel–Cox 
test. The statistical significance was set at p < 0.05. SPSS 
v15.0 for Windows statistical software package was used 
for statistical analysis.
Results
The anonymized database contained 355 patients and 
823 implants. However, 442 implants were excluded as 
142 had incomplete data related to study variables, 261 
had not been placed in the same region, 2 were inserted 
before implant removal, 35 had follow-up less than 
12  months, and 2 were not loaded (Fig.  1). One hun-
dred and forty six patients had 381 dental implants that 
were placed in the same position or one-tooth position 
mesially/distally to the site of explantation. The patients’ 
mean age was 63 ± 10 years (range: 29–84 years). Ninety-
seven patients were females and 49 were males. Fifty one 
(13%) of the implants removed due to the peri-implanti-
tis was placed by the same surgeon who placed the new 
implants. The other 330 (87%) of the removed implants 
were placed by other surgeons.
One hundred sixty four (43%) implants were inserted 
in the same surgical session as another implant was 
removed due to peri-implantitis. The other 217 (57%) 
implants were placed in a second surgical session 
after implant removal. This second intervention was 
performed 5 ± 9  months (range: 1–75  months) after 
implant removal. Overall, 245 (60%) implants were 
placed in pristine bone (one position mesial/distal 
to the removed implant) and 136 (36%) in regener-
ated bone (the same position as the removed implant). 
Figures  2 and 3 show the distribution of the implants 
diameter and length, respectively. Two hundred and 
forty eight (65%) implants were short (length < 8  mm) 
and 102 were extra-short in length (≤ 6.5 mm). Regard-
ing implant diameter, 112 (29%) implants were narrow 
Fig. 1 Study flow chart
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(diameter < 3.75  mm). The Mean insertion torque was 
44 ± 16 Ncm (range: 5–75 Ncm).
After a mean follow-up of 34 ± 17  months (range: 
12–82  months), two implants failed. The cumulative 
survival rate was 99% (Fig.  4). The marginal bone loss 
was −0.1 ± 0.6 (range: −5.3 to 1.9  mm). Two hun-
dred and eighteen (57%) implants showed marginal 
bone loss and 148 implants had it ≤ −0.5  mm (Fig.  5). 
Only 4 (1%) implants (2 supporting partial prosthe-
sis and 2 complete prosthesis) in 4 patients presented 
marginal bone loss greater than 2  mm from the basal 
level. The follow-up time of these implants were 17, 
38, 39 and 78 months. For marginal bone loss ≥ 3 mm, 
3 implants in 3 patients were affected with follow-up 
time of 17, 38, and 78 months. One hundred and sixty 
one (42%) implants had no marginal bone loss. Taking 
together implant survival and marginal bone loss data, 
309 (81%) implants survived and had a marginal bone 
loss ≤ −0.5  mm. Considering the success criteria sug-
gested by Buser et al. [12] the implant success rate was 
99.5%. According to the health scale of dental implants 
[13], 98.4% of the dental implants had optimal health 
and had been considered as a success. Replacing the 
removed implant immediately (same surgical session) 
or delayed had no significant influence on marginal 
bone loss (p value = 0.839). For the immediate replace-
ment, the marginal bone loss was −0.1 ± 0.7  mm 
(range: −5.3–1.9 mm). For the delayed replacement, it 
was −0.1 ± 0.6 (range: −3.1–1.3 mm). Furthermore, no 
significant differences (p value = 0.765) were observed 
in implant survival (99% for both).
Prosthodontically, 256 (67%) implants were immedi-
ately loaded within the first 24 h after insertion. All the 
implants were screw-retained and restored using tran-
sepithelial (transmucosal) abutments. Two hundred and 
seven implants (54%) supported fixed partial prosthe-
ses and 166 (44%) supported fixed complete prosthesis. 
Seven (2%) implants supported a single crown. The fol-
lowing technical complications were observed: ceramic 
chipping (3 events), resin tooth fracture (1 event) and 
prosthetic screw loosening (1 event).
Discussion
In a recent systematic review by Rakic et  al. the preva-
lence of peri-implantitis has been estimated to be 18.5% 
at the patient level and 12.8% at the implant level [14]. 
There is a clinical need for the establishment of effective 
protocols for the treatment of peri-implantitis that can 
achieve long-term outcomes. In the study by Carcuac 
et  al. different levels of outcomes have been described 
[15]. The most strict definition has been further marginal 
bone loss ≤ 0.5 mm, probing depth ≤ 5 mm and absence 
of bleeding or suppuration on probing. This has been 
considered as the peri-implantitis treatment success [16]. 
Following this definition, treatment success has been only 
achieved in about one third of the dental implants that 
were treated for peri-implantitis [15, 17]. Which indicate 
a clinical need to keep on researching to improve these 
figures.
However, in the clinical practice, success could be the 
no progression of the disease and the survival of the den-
tal implant [16]. The success (implant survival + further 
MBL ≤ 0.5 mm) has been achieved in 57% of the implants 
after 3  years of follow-up [15]. At 5  years of follow-up, 
56.2% of the implants has survived, not retreated or has 
marginal bone loss ≤ 1  mm [18]. Several factors may 
influence the success of peri-implantitis treatment. With 
5-year follow-up data, it has been observed that the 
Fig. 2 Dental implant diameter
Fig. 3 Dental implant length
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presence of residual deep probing depth, reduced mar-
ginal bone level and modified implant surface are factors 
that have increased the risk of recurrence/progression of 
the disease [18].
Mardinger et  al. have indicated the removal of a fail-
ing implant as soon as it is diagnosed as hopeless will 
improve the chances for reimplantation [19]. This will 
also prevent further tissue destruction. However, very 
few reports are available on the clinical outcomes on 
placing a dental implants in a region previously affected 
by peri-implantitis [20]. Similar to periodontitis, peri-
implantitis is an inflammatory process that is triggered 
by bacterial plaque and affects peri-implant soft and 
hard tissue [21]. In patients with periodontitis, implant 
survival rate has been about 90% [22–24]. Lee et al. have 
concluded that there is a strong evidence to suggest that 
periodontitis is a risk factor for implant loss [25].
This study has been conducted to assess the sur-
vival and marginal bone loss of dental implants replac-
ing dental implants failed due to peri-implantitis in the 
context of routine dental practice. The study outcomes 
have indicated high implant survival rate and marginal 
bone stability. The cumulative implant survival rate was 
99% and the marginal bone loss was −0.1 ± 0.6 (range: 
−5.3 to 1.9 mm). Only 3 (< 1%) implants presented mar-
ginal bone loss ≥ 3  mm after a mean follow-up time of 
44 ± 31  months. According to the health scale of dental 
implants, 98.4% of the dental implants had optimal health 
Fig. 4 Cumulative implant survival rate
Fig. 5 Changes in the level of the marginal follow-up over time. (−) 
indicates loss and (+) indicates gain
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[13]. Considering the success criteria suggested by Buser 
et al. the implant success rate was 99.5% [12]. In another 
study, immediate implant placement in the same socket 
of extracted implant due to peri-implantitis has shown 
high survival rate and marginal bone stability [20]. It has 
been hypothesized that the decrease in the bacterial load 
through the removal of the infected implant, the removal 
of the granulation tissue by  adequate socket curet-
tage and the mechanical decontamination of the socket 
by drilling would enhance the probability of implant sur-
vival [20]. The survival of implants immediately placed in 
infected and non-infected sockets has not shown statisti-
cally significant differences [26, 27]. A systematic review 
has been concluded that implants may be successfully 
osseointegrated when placed immediately after extrac-
tion of teeth due to endodontic and periodontal lesions 
[28].
In the present study 309 (81%) implants have survived 
and have shown a marginal bone loss ≤ 0.5 mm. Carcuac 
et  al. have reported the achievement of this outcome 
in 57% after 3  years of follow-up of surgically treated 
implants for peri-implantitis [15]. For that, the replace-
ment of dental implant affected by peri-implantitis has 
resulted in good clinical outcomes in term of implant 
survival and marginal bone stability.
This study suffers from the limitation of retrospective 
design, where there is dependency on the availability and 
accuracy of the clinical records. The absence of a control 
group limits the extrapolation of the results of this study. 
However, the study presents the outcome in the context 
of routine clinical practice, where 381 implants in 146 
patients have been assessed. The outcomes of this study 
justify the performance of a prospective and controlled 
clinical study to assess the clinical performance of dental 
implants replacing failed implant due to peri-implantitis.
Conclusions
When a dental implant affected by peri-implantitis fails, 
there is a need to replace that implant. Insight of the 
results of this study, the survival and marginal bone loss 
of replacement implants support this option for the man-
agement of failed implants due to peri-implantitis. Nev-
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